Cargando…

Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021

BACKGROUND: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. METHODS: We performed a retrospective analysis of antimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Loftus, Michael J., Everts, Richard J., Cheng, Allen C., Eti, Perenise, Fakasiieiki, Timote, Isaia, Lupeoletalelei, Isopo, Enita, Jenney, Adam W.J., Lameko, Viali, Leaupepe, Hinauri, Leavai, Folototo, Lee, Sue J., Moungaevalu, Mele, Stewardson, Andrew J., Tekoaua, Rosemary, Tou, Douglas, Wuatai, Geoffrey, Peleg, Anton Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926303/
https://www.ncbi.nlm.nih.gov/pubmed/36798514
http://dx.doi.org/10.1016/j.lanwpc.2022.100677
_version_ 1784888251377516544
author Loftus, Michael J.
Everts, Richard J.
Cheng, Allen C.
Eti, Perenise
Fakasiieiki, Timote
Isaia, Lupeoletalelei
Isopo, Enita
Jenney, Adam W.J.
Lameko, Viali
Leaupepe, Hinauri
Leavai, Folototo
Lee, Sue J.
Moungaevalu, Mele
Stewardson, Andrew J.
Tekoaua, Rosemary
Tou, Douglas
Wuatai, Geoffrey
Peleg, Anton Y.
author_facet Loftus, Michael J.
Everts, Richard J.
Cheng, Allen C.
Eti, Perenise
Fakasiieiki, Timote
Isaia, Lupeoletalelei
Isopo, Enita
Jenney, Adam W.J.
Lameko, Viali
Leaupepe, Hinauri
Leavai, Folototo
Lee, Sue J.
Moungaevalu, Mele
Stewardson, Andrew J.
Tekoaua, Rosemary
Tou, Douglas
Wuatai, Geoffrey
Peleg, Anton Y.
author_sort Loftus, Michael J.
collection PubMed
description BACKGROUND: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. METHODS: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries – the Cook Islands, Kiribati, Samoa and Tonga – between 2017 and 2021. We focused on four bacteria that have been identified as ‘Priority Pathogens’ by the World Health Organization: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. FINDINGS: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was E. coli (n = 8455) followed by S. aureus (n = 7830), K. pneumoniae (n = 2689) and P. aeruginosa (n = 1928). The prevalence of methicillin resistance among S. aureus isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among E. coli (87%–94%) and K. pneumoniae (72%–90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%–54% and 43%–61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%–99%). INTERPRETATION: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. FUNDING: Supported by the 10.13039/501100000925National Health and Medical Research Council.
format Online
Article
Text
id pubmed-9926303
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99263032023-02-15 Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021 Loftus, Michael J. Everts, Richard J. Cheng, Allen C. Eti, Perenise Fakasiieiki, Timote Isaia, Lupeoletalelei Isopo, Enita Jenney, Adam W.J. Lameko, Viali Leaupepe, Hinauri Leavai, Folototo Lee, Sue J. Moungaevalu, Mele Stewardson, Andrew J. Tekoaua, Rosemary Tou, Douglas Wuatai, Geoffrey Peleg, Anton Y. Lancet Reg Health West Pac Articles BACKGROUND: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. METHODS: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries – the Cook Islands, Kiribati, Samoa and Tonga – between 2017 and 2021. We focused on four bacteria that have been identified as ‘Priority Pathogens’ by the World Health Organization: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. FINDINGS: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was E. coli (n = 8455) followed by S. aureus (n = 7830), K. pneumoniae (n = 2689) and P. aeruginosa (n = 1928). The prevalence of methicillin resistance among S. aureus isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among E. coli (87%–94%) and K. pneumoniae (72%–90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%–54% and 43%–61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%–99%). INTERPRETATION: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. FUNDING: Supported by the 10.13039/501100000925National Health and Medical Research Council. Elsevier 2023-02-02 /pmc/articles/PMC9926303/ /pubmed/36798514 http://dx.doi.org/10.1016/j.lanwpc.2022.100677 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Loftus, Michael J.
Everts, Richard J.
Cheng, Allen C.
Eti, Perenise
Fakasiieiki, Timote
Isaia, Lupeoletalelei
Isopo, Enita
Jenney, Adam W.J.
Lameko, Viali
Leaupepe, Hinauri
Leavai, Folototo
Lee, Sue J.
Moungaevalu, Mele
Stewardson, Andrew J.
Tekoaua, Rosemary
Tou, Douglas
Wuatai, Geoffrey
Peleg, Anton Y.
Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
title Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
title_full Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
title_fullStr Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
title_full_unstemmed Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
title_short Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
title_sort antimicrobial susceptibility of bacterial isolates from clinical specimens in four pacific island countries, 2017–2021
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926303/
https://www.ncbi.nlm.nih.gov/pubmed/36798514
http://dx.doi.org/10.1016/j.lanwpc.2022.100677
work_keys_str_mv AT loftusmichaelj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT evertsrichardj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT chengallenc antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT etiperenise antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT fakasiieikitimote antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT isaialupeoletalelei antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT isopoenita antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT jenneyadamwj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT lamekoviali antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT leaupepehinauri antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT leavaifolototo antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT leesuej antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT moungaevalumele antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT stewardsonandrewj antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT tekoauarosemary antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT toudouglas antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT wuataigeoffrey antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021
AT pelegantony antimicrobialsusceptibilityofbacterialisolatesfromclinicalspecimensinfourpacificislandcountries20172021